Sign in

NCT07510568Not yet recruitingPhase 4

Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregnancy, and Other Adverse Maternal and Foetal Outcomes

Vitamin D Supplementation Among Pregnant Women in Uganda and for the Prevention of Adverse Obstetric Outcomes: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 3 Apr 2026

Brief summary (registry, in English)

The goal of this randomised controlled trial is to investigate if vitamin D supplementation among pregnant women in Uganda prevents adverse maternal and foetal outcomes, with special emphasis on preeclampsia. The main question it aims to answer is if Vitamin D supplementation, administered as oral vitamin D₃ at a dose of 2,000 IU once daily, from the time of recruitment to the time of delivery, reduces the incidence of preeclampsia, eclampsia and HELLP syndrome in pregnant women attending ANC at St. Mary's Hospital, Lacor, such incidence being monitored up to six (6) weeks after delivery. Researchers will compare the effect of oral 2.000 IU vitamin D daily (intervention group) vs. oral placebo daily (control group) on the prevalence of adverse maternal and foetal outcomes.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
1980 (estimated)
First submitted
22 Mar 2026
Start date
1 Jun 2026
Primary completion date
31 Dec 2027
Lead sponsor
St Mary's Hospital, Lacor
NCT number
NCT07510568

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 1980
  • From 1 Jun 2026 to the primary completion date, 31 Dec 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • women already on Vitamin D treatment prescribed by a physician.

Who the study is looking for

  • Women of age ≥ 18 years, who attend ANC services at St. Mary's Hospital Lacor, satisfying the following criteria:
  • with a viable intrauterine pregnancy,
  • at gestational age at recruitment between 13 weeks 0 days and 27 weeks 6 days, and
  • who consented to participate in the study.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.